New nucleoside and nucleotide analogues will be prepared and studies as antiviral and antitumor agents. These compounds will include: (i) enantiomeric antiviral methylenecyclopropane nucleoside analogues, (ii) lipophilic phosphate prodrugs, phosphonates and triphosphates of methylenecyclopropane analogues, (iii) methylenecycloalkane nucleoside analogues with cyclobutane, cyclopentane,and cyclohexane ring systems and (iv) gem-difluoromethylenecyclopropane analogues. Antiviral effects will be studied in a number of viral assays including human and murine cytomegalovirus (HCMV and MCMV), herpes simplex virus type 1 and 2 (HSV-1 and HSV-2) and human immunodeficiency (HIV). In vivo activity and mechanism of action of active compounds will also be investigated. Selected analogues will also be studies as potential antitumor agents.
Showing the most recent 10 out of 55 publications